Ghent University Academic Bibliography

Journal Article
A1
open access

Radical cystectomy or trimodality therapy for muscle-invasive bladder cancer : a qualitative study exploring patient priorities and counselling needs when making a treatment choice

Flor Verghote (UGent) , Charles Van Praet (UGent) , Camille Berquin, Nicolaas Lumen (UGent) , Karel Decaestecker (UGent) , Ben Vanneste (UGent) , Elke Rammant (UGent) and Valerie Fonteyne (UGent)

(2024) BMC CANCER. 24(1).

Add to list

The current use of the EORTC QLQ-NMIBC24 and QLQ-BLM30 questionnaires for the assessment of health-related quality of life in bladder cancer patients : a systematic review

Elke Rammant (UGent) , L. Fox, K. Beyer, N. K. Aaronson, R. Chaloner, S. De Padova, F. Liedberg, L. M. Wintner, Karel Decaestecker (UGent) , Valerie Fonteyne (UGent) , et al.

(2023) QUALITY OF LIFE RESEARCH. 32(8). p.2127-2135

Add to list

Journal Article
A1
open access

Experiences of men with prostate cancer participating in a clinical pathway with a supervised group-based exercise program to combat androgen deprivation-induced side effects : a qualitative focus group study

Renée Bultijnck (UGent) , Elke Rammant (UGent) , Anneleen Raes (UGent) , Nathalie Vandecasteele (UGent) , Karel Decaestecker (UGent) , Valerie Fonteyne (UGent) , Nicolaas Lumen (UGent) , Piet Ost (UGent) and Benedicte Deforche (UGent)

(2023) SEMINARS IN ONCOLOGY NURSING. 39(3).

Add to list

Physical activity and health-related quality of life from diagnosis to one year after radical cystectomy in patients with bladder cancer : a longitudinal cohort study

Elke Rammant (UGent) , Ann Van Hecke (UGent) , Jelle Van Cauwenberg (UGent) , Karel Decaestecker (UGent) , Lindsay Poppe (UGent) , Beth Russel, Renée Bultijnck (UGent) , Maarten Albersen, Sofie Verhaeghe (UGent) , Mieke Van Hemelrijck, et al.

(2022) BLADDER CANCER. 8(4). p.395-404

Add to list

Supportive care needs and utilization of bladder cancer patients undergoing radical cystectomy : a longitudinal study

Elke Rammant (UGent) , Ann Van Hecke (UGent) , Karel Decaestecker (UGent) , Maarten Albersen, Steven Joniau, Wouter Everaerts, Femke Jansen, Nihal E. Mohamed, Roos Colman (UGent) , Mieke Van Hemelrijck, et al.

(2022) PSYCHO-ONCOLOGY. 31(2). p.219-226

Add to list

Journal Article
A1
open access

Adjuvant radiotherapy after radical cystectomy for patients with high-risk muscle-invasive bladder cancer : results of a multicentric phase II trial

Valerie Fonteyne (UGent) , P. Dirix, Charles Van Praet (UGent) , C. Berghen, M. Albersen, S. Junius, N. Liefhooghe, L. Noé, G. De Meerleer, Piet Ost (UGent) , et al.

(2022) EUROPEAN UROLOGY FOCUS. 8(5). p.1238-1245

Add to list

Journal Article
A1
open access

Long-term outcomes and genetic predictors of response to metastasis-directed therapy versus observation in oligometastatic prostate cancer : analysis of STOMP and ORIOLE trials

MP Deek, K Van der Eecken, P Sutera, RA Deek, Valerie Fonteyne (UGent) , AA Mendes, Karel Decaestecker (UGent) , AP Kiess, Nicolaas Lumen (UGent) , R Phillips, et al.

(2022) JOURNAL OF CLINICAL ONCOLOGY. 40(29). p.3377-3382

Add to list

18F-PSMA-11 Versus 68Ga-PSMA-11 positron emission tomography/computed tomography for staging and biochemical recurrence of prostate cancer : a prospective double-blind randomised cross-over trial

Kathia De Man (UGent) , Nick Van Laeken (UGent) , Vanessa Schelfhout (UGent) , Wolfgang P. Fendler, Bieke Lambert (UGent) , Ken Kersemans (UGent) , Sarah Piron (UGent) , Nicolaas Lumen (UGent) , Karel Decaestecker (UGent) , Valerie Fonteyne (UGent) , et al.

(2022) EUROPEAN UROLOGY. 82(5). p.501-509

Add to list

Exercise prescription dose for castrate-resistant prostate cancer patients : a phase I prescription dose escalation trial

Renée Bultijnck (UGent) , Benedicte Deforche (UGent) , Noëmi Borrey (UGent) , Jörgen Van Bauwel (UGent) , Maarten Lievens (UGent) , Elke Rammant (UGent) , Valerie Fonteyne (UGent) , Karel Decaestecker (UGent) , Adelheid Steyaert (UGent) , Nicolaas Lumen (UGent) , et al.

(2021) WORLD JOURNAL OF UROLOGY. 39(2). p.357-364

Add to list

Journal Article
A1
open access

Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC) : a phase II prospective trial

Flor Verghote (UGent) , Lindsay Poppe (UGent) , Sofie Verbeke (UGent) , Piet Dirix, Maarten Albersen, Gert De Meerleer, Charlien Berghen, Piet Ost (UGent) , Geert Villeirs (UGent) , Pieter De Visschere (UGent) , et al.

(2021) BMC CANCER. 21(1).

Academic Bibliography

Radical cystectomy or trimodality therapy for muscle-invasive bladder cancer : a qualitative study exploring patient priorities and counselling needs when making a treatment choice

The current use of the EORTC QLQ-NMIBC24 and QLQ-BLM30 questionnaires for the assessment of health-related quality of life in bladder cancer patients : a systematic review

Experiences of men with prostate cancer participating in a clinical pathway with a supervised group-based exercise program to combat androgen deprivation-induced side effects : a qualitative focus group study

Physical activity and health-related quality of life from diagnosis to one year after radical cystectomy in patients with bladder cancer : a longitudinal cohort study

Supportive care needs and utilization of bladder cancer patients undergoing radical cystectomy : a longitudinal study

Adjuvant radiotherapy after radical cystectomy for patients with high-risk muscle-invasive bladder cancer : results of a multicentric phase II trial

Long-term outcomes and genetic predictors of response to metastasis-directed therapy versus observation in oligometastatic prostate cancer : analysis of STOMP and ORIOLE trials

18F-PSMA-11 Versus 68Ga-PSMA-11 positron emission tomography/computed tomography for staging and biochemical recurrence of prostate cancer : a prospective double-blind randomised cross-over trial

Exercise prescription dose for castrate-resistant prostate cancer patients : a phase I prescription dose escalation trial

Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC) : a phase II prospective trial

Contents

Support

Contact